ZimVie Inc at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. Welcome. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to host ZimVie for our next session. I'm going to bring up President and CEO, Vafa Jamali, and then we'll do some Q&A afterwards. Vafa?
Thanks, Robbie. Thanks very much. Very, very happy to be here. I'm Vafa Jamali, and I'd like to tell you a little bit about ZimVie, who we are and a little bit about what we're focused on and what the future looks like and why you should be excited to watch our progress. So this disclaimer, I'll allow you to read this on your own.
Really, when we started this company, we spun off of a company called Zimmer Biomet on March 1, 2022. So we've been independent for about 9 months. And we set out to have a vision. Our vision was everyone deserves to feel better, healthier and stronger, and we create solutions for people to enjoy and experience life. Our mission is to advance clinical
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |